NCT01757652: Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma |
|
|
| Recruiting | 2 | 32 | US | anti-endoglin monoclonal antibody TRC105, TRC105, pharmacological study, pharmacological studies, laboratory biomarker analysis, quality-of-life assessment, quality of life assessment | National Cancer Institute (NCI) | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor | 01/00 | | | |
